InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

Why is Nike selling on Amazon again? How are tariffs impacting U.S. retailers? What caused the recent Dow stock plunge? Why did AT&T buy Lumen's fiber business? How will OpenAI's deal with Jony Ive affect Apple? Why are Target's sales and forecast slumping? What’s driving Bitcoin’s all-time high surge? Why is Newark Airport limiting flights this summer? How will GOP’s tax bill affect Medicare?

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

forbes.com/sites/innovationrx/2025/05/21/innovationrx-fda-will-limit-covid-19-vaccines-to-those-over-65-or-at-high-risk

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, Medtronic’s diabetes spinoff, Regeneron’s purchase of 23AndMe, and more.

This story appeared on forbes.com, 2025-05-21 16:00:55.